A crucial aspect of regenerative medicine and drug discovery lies in the ability to multiply human stem cell populations to sufficient amounts for therapeutic applications. Traditionally, limited cell presence posed a significant obstacle to advancement in these fields. Consequently, considerable endeavor has been directed towards improving protoco